AstraZeneca-Aktie: AstraZeneca verhandelt Milliardendeal mit Summit Therapeutics Der britische Pharmakonzern spreche derzeit mit Summit Therapeutics über eine Vereinbarung, in deren Rahmen AstraZeneca über mehrere Jahre bis zu…
Summit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reports Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported on Thursday,…
GOLDMAN SACHS stuft ASTRAZENECA auf Buy NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Astrazeneca von 14524 auf 14806 Pence angehoben…
What If London Loses One Of Its Top Companies? Suggestions that AstraZeneca might cross the Atlantic should act as a huge wake-up call.…
London stock market could weather its biggest blow yet if AstraZeneca exits AstraZeneca is the most valuable company listed on London’s FTSE 100 index.…
London’s New Listings Hit 28-Year Low as AstraZeneca Weighs Exit London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca…
Astrazeneca (AZN) Advances While Market Declines: Some Information for Investors Astrazeneca (AZN) reached $71.46 at the closing of the latest trading day, reflecting a +2.26% change compared to its last…
Why AstraZeneca Stock Topped the Market on Tuesday Trading in AstraZenecas (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to…
AstraZeneca boss ‘wants to shift stock market listing to US’ Report claims CEO Pascal Soriot talked in private about moving UK’s most valuable listed company and considered shifting its domicile…
AstraZeneca ‘may quit London stock market’ Pharma giant’s chief discusses shifting listing to US in potential blow to UK capital…
AstraZeneca reports total voting rights at over 1.55 billion shares By Investing.com AstraZeneca reports total voting rights at over 1.55 billion shares…
AstraZeneca CEO eyes US market listing, The Times reports AstraZeneca chief executive Pascal Soriot is considering moving the companys stock market listing to the United States, The Times reported…
AstraZeneca CEO wants to move Britain’s most valuable company to US Sir Pascal Soriot is frustrated with restrictions on medicines by Nice and pricing under an NHS rebate scheme…
IEFA Is a Great Choice for Most, but I Like VEA ETF Better For investors in the United States, its pretty easy to get overexposed to domestic stocks. These are the brands that…